Loss of SIRT2 reduces AMP-activated protein kinase (AMPK) activation, promotes aging-related and Ang II-induced cardiac hypertrophy, which indicates that SIRT2 could be a potential target for therapeutic interventions in aging- and stress-induced cardiac hypertrophy (Tang et al., 2017). The gene discussed is AGT; the disease is cardiac hypertrophy.